drug
as of 2026-07-01vabicaserin
MeSH C556517
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Wyeth is now a wholly owned subsidiary of Pfizer
2 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
2
Study Evaluating Vabicaserin in Subjects With Schizophrenia
NCT00563706Phase 2Completed
Study Comparing Bioavailability of Oral Formulations of Vabicaserin
NCT00541996Phase 1Completed
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication
indication
indication